We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era.
- Authors
Shah, Mithun V.; Saliba, Rima M.; Varma, Ankur; Ciurea, Stefan O.; Oran, Betul; Olson, Amanda; Bose, Prithviraj; Bashir, Qaiser; Masarova, Lucia; Alousi, Amin M.; Srour, Samer; Mehta, Rohtesh S.; Daver, Naval; Pemmaraju, Naveen; Verstovsek, Srdan; Champlin, Richard E.; Popat, Uday R.
- Abstract
Keywords: myeloproliferative disorders; hematopoietic stem cell transplantation; acute myeloid leukemia, secondary; disease, minimal residual EN myeloproliferative disorders hematopoietic stem cell transplantation acute myeloid leukemia, secondary disease, minimal residual 1004 1008 5 06/05/21 20210601 NES 210601 I BCR-ABL1 i (Philadelphia chromosome)-negative myeloproliferative neoplasms (MPN) are a heterogeneous group of haematological malignancies. Among 36 patients that received pre-SCT therapy, pre-SCT disease status was: CR1 8%; marrow CR 35%; and no response 50%.
- Subjects
STEM cell transplantation; HEMATOPOIETIC stem cell transplantation; MYELOPROLIFERATIVE neoplasms
- Publication
British Journal of Haematology, 2021, Vol 193, Issue 5, p1004
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/bjh.17423